Cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients previously diagnosed with cardiovascular disease; (2) Both male or female aged 18-70 years old; (3) Voluntarily participate in this clinical trial provide informed consent and sign the informed consent form.Both
Exclusion criteria
Exclusion criteria: (1) Merge with other serious organic diseases. (2) Acute myocardial infarction or interventional treatment within the past 6 months, heart failure patients (classified as III-IV according to NYHA classification) (3) There is a history of contraindications or allergies to medicinal and edible decoctions. (4) There is a serious impairment in liver and kidney function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver disease;Life quality;Kidney disease;Lung disease;Sleep quality; | — |
Countries
China
Contacts
South China Hospital of Shenzhen University